Is Molecular Data a Chinese Stock Worth Buying?

: MKD | Molecular Data Inc. ADR News, Ratings, and Charts

MKD – The shares of Chinese tech-driven platform Molecular Data (MKD) have been foundering over the past year on increased concerns regarding the stock’s potential delisting from U.S. exchanges and the company’s poor financials. So, as the markets gradually stabilize, will MKD be able to regain its momentum? Let’s discuss.

Headquartered in Shanghai, China, Molecular Data Inc. (MKD) is a technology-driven platform operating in the Chinese chemical industry. It offers e-commerce, financial, warehousing and logistics solutions to several companies, thereby connecting them along the chemical value chain.

MKD’s shares have slumped 81% in price over the past year and 20.7% over the past six months to close Friday’s trading session at $0.23. 

Despite the booming global chemical industry, shares of MKD have been retreating due to concerns surrounding their potential delisting from U.S. stock exchanges given the SEC’s increased scrutiny of  Chinese ADRs.

Here is what could shape MKD’s performance in the near term:

Equity Dilution

Last September, MKD sold 23.39 million common units, each comprising one ADR and one warrant, at $0.38 each to institutional investors. The company also sold 16.08 million pre-funded units, each containing one pre-funded warrant and one purchase warrant through this direct equity offering. The warrants are exercisable for up to five years from the date of issuance.

MKD raised $15 million in gross proceeds from this offering, which it plans to utilize to fund its general corporate expenses and working capital. However, its total outstanding shares increased significantly through this offering, thereby reducing its earnings per share and return on equity. Furthermore, its share capital is expected to be further diluted as warrants are exercised over the next few years.

Non-Compliance of Nasdaq Marketplace Rule

Last November, MKD received an extension of an additional 180 days (until May 23, 2022) to regain compliance with Nasdaq’s Minimum Bid Price Rule. The company’s shares are required to trade at a minimum price of $1 for at least 10 consecutive days to remain listed on the Nasdaq Capital market. The stock closed the last trading session at $0.23.

MKD previously received a notice from the Nasdaq stock exchange in May 2021 regarding non-compliance with the Minimum Bid Price Rule. The company was granted 180 days to regain compliance until Nov. 22, 2021. However, the company failed to regain compliance during that period, following which it was granted an extension. MKD announced its plan to administer a reverse stock split, if necessary, to regain compliance.

POWR Ratings Reflect Bleak Prospects

MKD has an overall D rating, which equates to Sell in our proprietary POWR Ratings system. The POWR Ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree.

MKD has a grade of D for Stability and a C for Quality. The stock has a maximum drawdown of 36.67, which is in sync with the Stability grade. In addition, the company’s trailing-12-month levered free cash flow margin of 1.32% is 72.9% lower than the 4.87% industry average, justifying the Quality grade.

Of the 96 stocks in the Chemicals industry, MKD is ranked #87.

Beyond what I have stated above, view MKD ratings for Growth, Sentiment, Value, and Momentum here.

Bottom Line

Despite being an award-winning tech-driven platform, MKD’s trailing-12-month profit margins are negative, while its trailing-12-month revenues slumped 63.1% year-over-year. Furthermore, shares of MKD listed on the Nasdaq stock exchange are at the risk of delisting because the company has fallen afoul of the exchange’s Minimum Bid Price Rule. Thus, we think the stock is best avoided now.

How Does Molecular Data (MKD) Stack Up Against its Peers?

While MKD has a D rating in our proprietary rating system, one might want to consider looking at its industry peers, Valhi, Inc. (VHI), ICL Group Ltd. (ICL), and Mitsubishi Chemical Holdings Corporation (MTLHY), which have an A (Strong Buy) rating.

Want More Great Investing Ideas?

REVISED: 2022 Stock Market Outlook

3 Stocks to DOUBLE This Year

Top 10 Stocks for 2022

7 SEVERELY Undervalued Stocks

MKD shares were trading at $0.22 per share on Monday morning, down $0.01 (-4.72%). Year-to-date, MKD has gained 0.92%, versus a -6.31% rise in the benchmark S&P 500 index during the same period.

About the Author: Aditi Ganguly

Aditi is an experienced content developer and financial writer who is passionate about helping investors understand the do’s and don'ts of investing. She has a keen interest in the stock market and has a fundamental approach when analyzing equities. More...

More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
MKDGet RatingGet RatingGet Rating
VHIGet RatingGet RatingGet Rating
ICLGet RatingGet RatingGet Rating
MTLHYGet RatingGet RatingGet Rating

Most Popular Stories on

:  |  News, Ratings, and Charts

The WORST Stock Market Ever!

It’s been a while since I talked to anyone enjoying the recent stock market action. Too volatile. Too illogical. No real trend. All true. However, the more we understand why this is happening the easier to diagnose what will happen from here and how we can trade our way to profits. (Spoiler Alert) I am still bearish. Gladly I still see 7 timely trades to use to make money as the S&P 500 (SPY) heads lower from here. Read on below for the full story…

:  |  News, Ratings, and Charts

3 Highly-Rated Stocks Worth Buying Right Now

Despite macroeconomic headwinds, internet penetration is expected to increase in the foreseeable future, owing to consistent digital transformation. Moreover, with significant pent-up travel demand, fundamentally strong internet stocks Tripadvisor (TRIP), (DESP), and Travelzoo (TZOO) look poised to benefit in the near term. Hence, they might be worth buying before April. Read on…

:  |  News, Ratings, and Charts

1 Stock Investors Can't Get Enough Of

Consumer staples, like food, enjoy inelastic demand regardless of economic conditions. Amid the current inflationary atmosphere, fundamentally sound food-maker stock Grupo Bimbo (GRBMF) could be an ideal addition to one’s portfolio for steady returns. Continue reading...

:  |  News, Ratings, and Charts

3 of the Worst Stocks on Wall Street

Amid high inflation, banking failures in recent weeks, and tight monetary policy, the likelihood of an economic downturn has resurfaced. Given the gloomy market outlook, avoiding fundamentally weak stocks PAVmed (PAVM), PetVivo Holdings (PETV), and Sphere 3D (ANY) could be wise. Read more…

:  |  News, Ratings, and Charts

1 Stock Investors Can't Get Enough Of

Consumer staples, like food, enjoy inelastic demand regardless of economic conditions. Amid the current inflationary atmosphere, fundamentally sound food-maker stock Grupo Bimbo (GRBMF) could be an ideal addition to one’s portfolio for steady returns. Continue reading...

Read More Stories

More Molecular Data Inc. ADR (MKD) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All MKD News